Pharmaceutical Executive-10-01-2017

Pharm Exec’s 10th annual list of rising leaders highlights 11 pharma managers who are poised to help chart the industry’s path forward.

Today’s model requires a fourth partner-the systems integrator

FDA seeks to de-risk research and promote competition to achieve savings for patients and plans.

European Commission talks drug industry investment, health issues during State of the Union.

Pharma companies today must increasingly provide evidence on real-world outcomes to differentiate and justify their products. But what is the true potential of real-world evidence studies and what are the right questions to ask in determining product performance in the marketplace?

Pharma needs a reeducation on what it means to be compliant.

As we again highlight a roster of emerging leaders in pharma, I wanted to recognize Pharm Exec's own unique team behind the scenes.

Emerging as a bastion of peace, stability, and resilience in a region increasingly beset by political turbulence and economic stagnation, Colombia has been steadily reinventing itself as a Latin American pioneer and pacesetter, including in the world of healthcare.

Click the title above to open the Pharmaceutical Executive October 2017 issue in an interactive PDF format.